We are live on ! Find out more
PFX icon

PhenixFIN

17 hedge funds and large institutions have $26.7M invested in PhenixFIN in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

22% more capital invested

Capital invested by funds: $21.9M → $26.7M (+$4.83M)

6% more funds holding

Funds holding: 1617 (+1)

2.98% more ownership

Funds ownership: 27.58%30.56% (+3%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
5
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PFX Hedge Fund Activity: Q4 2023 in Review

17 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in PhenixFIN (PFX) for Q4 2023, worth a combined $26.7M — up 22% from $21.9M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PFX positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.46M. The largest seller was Northwestern Mutual Wealth Management, cutting an estimated $839K.

  • 17 institutional investors held PhenixFIN (PFX) as of Q4 2023, up from 16 in Q3 2023.
  • Funds reported $26.7M of PhenixFIN stock for Q4 2023, up 22% quarter-over-quarter.
  • 2 funds opened new PhenixFIN positions in Q4 2023 and 1 closed out, a net change of +1 holder.
  • The largest PhenixFIN buyer in Q4 2023 was Morgan Stanley, an estimated $2.46M added.
  • The largest PhenixFIN seller in Q4 2023 was Northwestern Mutual Wealth Management, an estimated $839K sold.

Based on aggregated 13F filings for Q4 2023.